Skip to main content
. 2021 Jan 14;11:1393. doi: 10.1038/s41598-021-81164-0

Figure 7.

Figure 7

Alternative first exon event in TPD52. (a) IGV RNA expression reads of both isoforms of TPD52 in LNCaP Vehicle, LNCaP R1881, LNCaP-AR-V7 Dox treated samples, VCaP Vehicle, VCaP R1881, and VCaP-AR-V7 Dox treated samples, ChIP-exo tracks in LNCaP R1881 and LNCaP-AR-V7 Dox treated samples and a FOXA1 ChIP track in the LNCaP cell line. (b) To analyze the expression of the promoter 2 and the promoter 1 isoforms, LNCaP and LNCaP-AR-V7 cells were transferred to CSS medium and treated with vehicle, R1881, or Dox for 24 h and RNA was isolated and subjected to qPCR. (c) LNCaP-AR-V7 cells were treated with control si or FOXA1-siRNA and cells were harvested at 72 h for western blotting and probed with FOXA1 and tubulin antibodies. (d) LNCaP-AR-V7 cells were treated with control si or si-FOXA1 for 48 h followed by treatment with vehicle, R1881, or Dox for an additional 24 h. RNA was isolated subjected to qPCR with primers for promoter 2 and promoter 1 isoforms.